Skip to main content

Department of Medicine Archives

Vanderbilt mourns loss of former Rheumatology director Thomas

Nov. 21, 2022—James Ward “Tom” Thomas II, MD, former director of Vanderbilt’s Division of Rheumatology and Immunology, died Nov. 16 following a battle with cancer. He was 74.

Read more


Surgery for hereditary breast cancer

Nov. 17, 2022—Similar rates of bilateral mastectomy in women with inherited mutations in high- and moderate-penetrance genes raises concerns about possible overtreatment of some patients, Vanderbilt researchers report.

Read more


A marker for mortality

Nov. 17, 2022—A urine biomarker of inflammation was associated with increased mortality and multiple lifestyle factors, suggesting that modifications could help reduce premature mortality.

Read more


Grants spur efforts to create molecular ‘atlases’ of organs

Nov. 17, 2022—Vanderbilt researchers have received three grants totaling $13.6 million from the National Institutes of Health to develop molecular “atlases” of the brain, kidney, eye and other tissues.

Read more


VUMC adopts updated kidney function equation to better guide patient care decisions

Nov. 17, 2022—In December Vanderbilt University Medical Center will again update the equation used for estimating kidney function with the goals of improving health equity and better guiding patient care decisions.

Read more


Study supports removing race from estimate of kidney function

Nov. 17, 2022—An in-depth analysis by Vanderbilt investigators of published research studies supports removing race from the calculation of estimated glomerular filtration rate (eGFR) — an assessment of kidney function.

Read more


Study finds inherited link to appendix cancer

Nov. 11, 2022—A Vanderbilt study is the first to show inherited risk factors for appendiceal cancer.

Read more


Hawiger still blazing a trail in inflammation research

Nov. 10, 2022—Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema.

Read more


Clinical trial at VUMC tests novel treatment for asthma

Nov. 10, 2022—VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.

Read more


Study explores CVD risk for people with HIV

Nov. 10, 2022—A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.

Read more


Infectious Diseases Society of America honors Wright

Nov. 10, 2022—Vanderbilt's Patty Wright, MD, is one of two recipients of the 2022 Watanakunakorn Clinician Award from the Infectious Diseases Society of America.

Read more


Brady named Executive Vice Dean for Academic Affairs

Nov. 1, 2022—Donald Brady, MD, has been appointed to an expanded oversight role of Executive Vice Dean for Academic Affairs for Vanderbilt University School of Medicine.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more